Related Experiment Video
Updated: Apr 18, 2026

07:29
Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
12.5K
Immunotherapy for head and neck squamous cell carcinoma.
Qiao Li1, Mark E P Prince1, Jeffrey S Moyer1
1University of Michigan Comprehensive Cancer Center, 1500 E Medical Center Dr., Ann Arbor, MI 48109, United States.
Oral Oncology
|January 28, 2015
Summary
Immunotherapy shows promise for head and neck squamous cell carcinoma (HNSCC). Research is exploring how to leverage new findings on immune suppression to improve treatment outcomes for HNSCC patients.
Area of Science:
- Oncology
- Immunology
- Head and Neck Cancer Research
Background:
- Head and neck squamous cell carcinoma (HNSCC) patients often exhibit an immunosuppressed state.
- This immune dysfunction is a significant factor contributing to poor prognoses in HNSCC.
- Targeting the immune system presents a promising therapeutic avenue for this challenging malignancy.
Purpose of the Study:
- To provide a comprehensive review of the current landscape of immunotherapy for HNSCC.
- To highlight the latest advancements and clinical trial data in HNSCC immunotherapy.
Main Methods:
- Systematic review of existing literature.
- Focus on analysis of data from clinical trials in HNSCC immunotherapy.
Main Results:
- HNSCC is characterized by a known state of immune suppression.
- This immunosuppression is linked to unfavorable patient outcomes.
- Immunomodulatory strategies are being investigated to enhance cancer treatment efficacy.
Conclusions:
- Ongoing research is elucidating the mechanisms behind HNSCC-associated immunosuppression.
- Novel immunotherapies are under development, aiming to capitalize on these emerging insights.
- These advancements hold potential for improving treatment responses in HNSCC.
Related Concept Videos
Tumor Immunotherapy
2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
Cancer Therapies
10.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.9K
Cancer Vaccines
1.4K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.4K
Targeted Cancer Therapies
9.2K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.2K
Combination Therapies and Personalized Medicine
6.4K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.4K

